Advanced Oncotherapy plc (LON:AVO – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1.77 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares traded.
Advanced Oncotherapy Price Performance
The stock has a fifty day moving average of GBX 1.75 and a 200-day moving average of GBX 1.77. The company has a quick ratio of 0.13, a current ratio of 1.26 and a debt-to-equity ratio of 98.71. The stock has a market capitalization of £9.49 million, a price-to-earnings ratio of -25.00 and a beta of 0.07.
Advanced Oncotherapy Company Profile
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Read More
- Five stocks we like better than Advanced Oncotherapy
- About the Markup Calculator
- Garmin Navigates to New Highs Driven By Wearables Trend
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What does consumer price index measure?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.